Myths vs facts: HbA1c and gut health

HbA1c (glycated hemoglobin) is a well-established marker of average blood glucose over 2–3 months, primarily driven by diet, insulin resistance, and diabetes management. A common myth is that a 'healthy gut' can directly and dramatically lower HbA1c. In reality, human studies show that the gut microbiome influences glucose metabolism via short-chain fatty acids (e.g., butyrate) and inflammation regulation, but the effect size is modest (HbA1c changes <0.3%) and insufficient to replace standard diabetes care. Another myth: HbA1c testing can assess gut health – false; HbA1c measures only blood glucose, not microbiome composition. Conversely, gut dysbiosis or increased intestinal permeability may worsen insulin sensitivity over time through systemic inflammation, indirectly affecting HbA1c. Evidence is moderate (human studies, but lacking large RCTs). For consumers: optimizing HbA1c requires blood sugar management (diet, exercise, medication if needed). Gut health can be supportive but is not a substitute. MyBody-X tests claiming a direct microbiome–HbA1c link should be viewed skeptically.